![1G1 [LS141-1G1-65-15-1]](https://pda.biobw.org/static/images/cells-no_picture.jpg)
-
平臺(tái)編號(hào)：bio-69019
-
國(guó)際編號(hào)：HB-12624?
-
細(xì)胞信息： 1G1 [LS141-1G1-65-15-1]
-
規(guī)格：frozen
-
用途：ATCC原裝細(xì)胞
-
服務(wù)費(fèi)用：
加載中…… - 訂購(gòu)
-
注意事項(xiàng)：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動(dòng)物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫為準(zhǔn)）
1G1 [LS141-1G1-65-15-1]
生長(zhǎng)狀態(tài)：懸浮生長(zhǎng)
ATCC Number：HB-12624?
數(shù)量：大量
細(xì)胞形態(tài)：淋巴樣
免疫類型：IgG1 kappa
是否是腫瘤細(xì)胞：0
物種來源：小鼠
運(yùn)輸方式：凍存運(yùn)輸
規(guī)格：0.5mg Designations: 1G1 [LS141-1G1-65-15-1]
Depositors: ?LeukoSite, Inc.
Isotype: IgG1 kappa
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:suspension
Organism: Mus musculus (B cell); Mus musculus (myeloma)
Morphology:lymphoblast
Source: Cell Type: hybridoma: lymphoblast B lymphocyte; somatic cell hybrid
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Comments:Animals were immunized with L1.2 cells expressing high levels of transfected CCR4.Spleen cells were fused with Sp2/0 myeloma cells.The cells produce immunoglobulin; monoclonal antibody; against human Chemokine Receptor 4 (CCR4).
Propagation: ATCC complete growth medium: Temperature: 37.0°C
Subculturing: Protocol: Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 3 X 10(4) viable cells/ml. Maintain cell density between 4 X 10(4) and 4 X 10(5) viable cells/ml. Do not exceed 7 X10(5) cells/ ml.
Medium Renewal: Add fresh medium every 2 to 3 days (depending on cell density)
Preservation: Freeze medium: Complete growth medium, extra 10% FBS; 7.5% DMSO
Storage temperature: liquid nitrogen vapor phase
Doubling Time: 19 hours
Related Products:Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2002
recommended serum:ATCC 30-2020
References: 71341: Wu L, et al. Anti-CCR4 antibodies and methods of use therefor. US Patent 6,488,930 dated Dec 3 2002
71429: Wilbanks A, et al. Expression cloning of the STRL33/BONZO/TYMSTRligand reveals elements of CC, CXC, and CX3C chemokines. J. Immunol. 188: 5145-5154, 2001. PubMed: 11290797
88727: Jones D, et al. Expression pattern of T-cell-associated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-Hodgkin lymphoma. Blood 96: 685-690, 2000. PubMed: 10887135
88932: Kim CH, et al. Rules of chemokine receptor association with T cell polarization in vivo. J. Clin. Invest. 108: 1331-1339, 2001. PubMed: 11696578
88933: Campbell JJ, et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 400: 776-780, 1999. PubMed: 10466728
ATCC Number：HB-12624?
數(shù)量：大量
細(xì)胞形態(tài)：淋巴樣
免疫類型：IgG1 kappa
是否是腫瘤細(xì)胞：0
物種來源：小鼠
運(yùn)輸方式：凍存運(yùn)輸
規(guī)格：0.5mg Designations: 1G1 [LS141-1G1-65-15-1]
Depositors: ?LeukoSite, Inc.
Isotype: IgG1 kappa
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:suspension
Organism: Mus musculus (B cell); Mus musculus (myeloma)
Morphology:lymphoblast
Source: Cell Type: hybridoma: lymphoblast B lymphocyte; somatic cell hybrid
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Comments:Animals were immunized with L1.2 cells expressing high levels of transfected CCR4.Spleen cells were fused with Sp2/0 myeloma cells.The cells produce immunoglobulin; monoclonal antibody; against human Chemokine Receptor 4 (CCR4).
Propagation: ATCC complete growth medium: Temperature: 37.0°C
Subculturing: Protocol: Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 3 X 10(4) viable cells/ml. Maintain cell density between 4 X 10(4) and 4 X 10(5) viable cells/ml. Do not exceed 7 X10(5) cells/ ml.
Medium Renewal: Add fresh medium every 2 to 3 days (depending on cell density)
Preservation: Freeze medium: Complete growth medium, extra 10% FBS; 7.5% DMSO
Storage temperature: liquid nitrogen vapor phase
Doubling Time: 19 hours
Related Products:Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2002
recommended serum:ATCC 30-2020
References: 71341: Wu L, et al. Anti-CCR4 antibodies and methods of use therefor. US Patent 6,488,930 dated Dec 3 2002
71429: Wilbanks A, et al. Expression cloning of the STRL33/BONZO/TYMSTRligand reveals elements of CC, CXC, and CX3C chemokines. J. Immunol. 188: 5145-5154, 2001. PubMed: 11290797
88727: Jones D, et al. Expression pattern of T-cell-associated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-Hodgkin lymphoma. Blood 96: 685-690, 2000. PubMed: 10887135
88932: Kim CH, et al. Rules of chemokine receptor association with T cell polarization in vivo. J. Clin. Invest. 108: 1331-1339, 2001. PubMed: 11696578
88933: Campbell JJ, et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 400: 776-780, 1999. PubMed: 10466728
